Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
LQDA Liquidia Technologies, Inc. daily Stock Chart
LQDA [NASD]
Liquidia Technologies, Inc.
Healthcare | Biotechnology | USA
statements
Index- P/E- EPS (ttm)-2.51 Insider Own27.90% Shs Outstand18.95M Perf Week-0.39%
Market Cap96.64M Forward P/E- EPS next Y-2.45 Insider Trans6.43% Shs Float11.29M Perf Month-27.14%
Income-42.80M PEG- EPS next Q-0.59 Inst Own62.20% Short Float2.07% Perf Quarter48.04%
Sales8.60M P/S11.24 EPS this Y-85.00% Inst Trans1.09% Short Ratio1.08 Perf Half Y-8.77%
Book/sh1.04 P/B4.90 EPS next Y1.60% ROA-71.30% Target Price36.33 Perf Year-67.68%
Cash/sh2.07 P/C2.46 EPS next 5Y- ROE-159.00% 52W Range2.65 - 20.05 Perf YTD19.30%
Dividend- P/FCF- EPS past 5Y- ROI-110.30% 52W High-74.56% Beta-
Dividend %- Quick Ratio2.90 Sales past 5Y- Gross Margin90.70% 52W Low92.45% ATR0.54
Employees63 Current Ratio2.90 Sales Q/Q- Oper. Margin- RSI (14)46.43 Volatility5.99% 9.78%
OptionableNo Debt/Eq0.92 EPS Q/Q-14.50% Profit Margin- Rel Volume0.24 Prev Close5.20
ShortableYes LT Debt/Eq0.65 EarningsFeb 25 BMO Payout- Avg Volume216.03K Price5.10
Recom1.70 SMA20-12.07% SMA502.22% SMA200-13.10% Volume52,779 Change-1.92%
Nov-08-18Resumed Jefferies Buy
Sep-05-18Initiated Wedbush Outperform $26
Aug-20-18Initiated Needham Buy $30
Aug-20-18Initiated Jefferies Buy $22
Jan-27-20 02:55PM  Liquidia seeks pivotal FDA approval for lead drug American City Business Journals -8.13%
08:00AM  Liquidia Submits New Drug Application for LIQ861 (treprostinil) inhalation powder to U.S. Food and Drug Administration for the Treatment of Pulmonary Arterial Hypertension (PAH) GlobeNewswire
Jan-24-20 09:00AM  Liquidia Announces Poster Presentation at the 14th Annual World Congress of the Pulmonary Vascular Research Institute (PVRI) GlobeNewswire -8.81%
Jan-15-20 07:29AM  Will Liquidia Continue to Surge Higher? Zacks +13.96%
Dec-26-19 02:55PM  Liquidia nets $22.4 million as it moves forward with lead drug American City Business Journals +43.47%
10:32AM  Liquidia Technologies stock soars after Wedbush says private placement gives company runway through Q4 2020 MarketWatch
Dec-24-19 08:30AM  Liquidia Technologies Announces $22.4 Million Private Placement GlobeNewswire +12.46%
Dec-20-19 06:21PM  Is Liquidia Technologies, Inc. (LQDA) A Good Stock To Buy? Insider Monkey
Nov-13-19 08:15AM  Liquidia Technologies, Inc. (LQDA) Reports Q3 Loss, Misses Revenue Estimates Zacks +8.45%
07:00AM  Liquidia Technologies Reports Third Quarter 2019 Financial Results and Provides Corporate Update GlobeNewswire
06:00AM  Liquidia Technologies, Inc. to Host Earnings Call ACCESSWIRE
Nov-06-19 08:00AM  Liquidia to Report Third Quarter 2019 Financial Results and Provide Corporate Update on November 13, 2019 GlobeNewswire -14.59%
Nov-01-19 08:00AM  Liquidia Technologies Appoints Industry Veteran Katie Rielly-Gauvin to Board of Directors GlobeNewswire +7.08%
Oct-23-19 10:33AM  Liquidia Technologies, Inc. (LQDA) May Report Negative Earnings: Know the Trend Ahead of Q3 Release Zacks +7.43%
Oct-22-19 10:52AM  Is Liquidia Technologies (NASDAQ:LQDA) Using Too Much Debt? Simply Wall St.
Sep-25-19 04:05PM  Liquidia to Present at Cantor 2019 Global Healthcare Conference GlobeNewswire
Sep-12-19 04:05PM  Liquidia Technologies Appoints Industry Veteran Dr. Joanna Horobin to Board of Directors GlobeNewswire
Sep-03-19 07:00AM  Liquidia to Present at H.C. Wainwright Healthcare Conference GlobeNewswire -18.97%
Aug-27-19 02:44PM  Morrisville's Liquidia seeks partner as it prepares to launch new drug American City Business Journals -17.57%
Aug-08-19 04:05PM  Liquidia to Present at Wedbush PacGrow Healthcare Conference GlobeNewswire +9.60%
07:00AM  Liquidia Technologies Reports Second Quarter 2019 Financial Results and Provides Corporate Update GlobeNewswire
Aug-02-19 09:00AM  Liquidia to Report Second Quarter 2019 Financial Results and Provide Corporate Update on August 8, 2019 GlobeNewswire -6.62%
Jul-24-19 01:01PM  Could Liquidia Technologies, Inc.'s (NASDAQ:LQDA) Investor Composition Influence The Stock Price? Simply Wall St.
Jun-28-19 08:35PM  Hedge Funds Have Never Been This Bullish On Liquidia Technologies, Inc. (LQDA) Insider Monkey
02:17PM  Behind Liquidia's new deal with GSK American City Business Journals
Jun-26-19 04:15PM  Liquidia and GSK Restructure Collaboration Agreement GlobeNewswire -5.01%
Jun-05-19 04:05PM  Liquidia Announces Clinical Update on INSPIRE; Targeting NDA Filing for LIQ861 in Late 2019 GlobeNewswire
Jun-03-19 08:30AM  Liquidia to Present at Jefferies Healthcare Conference GlobeNewswire
May-22-19 04:30PM  Liquidia Appoints Seasoned Biopharmaceutical Industry Executive Dr. Richard Katz as Chief Financial Officer GlobeNewswire
May-14-19 04:15PM  Liquidia Announces Poster Presentation at the American Thoracic Society (ATS) International Conference 2019 GlobeNewswire
May-02-19 07:00AM  Liquidia Technologies Reports First Quarter 2019 Financial Results and Provides Corporate Update GlobeNewswire -8.57%
Apr-23-19 04:05PM  Liquidia Technologies to Report First Quarter 2019 Financial Results and Provide Corporate Update on May 2, 2019 GlobeNewswire
Apr-03-19 04:30PM  Liquidia Technologies Presents Phase 3 Trial Data for LIQ861 at the ISHLT 39th Annual Meeting & Scientific Sessions GlobeNewswire
Apr-02-19 08:00AM  Liquidia Technologies to Present at Needham Healthcare Conference GlobeNewswire
Mar-25-19 10:54AM  Liquidia Technologies Announces Closing of Offering of Common Stock GlobeNewswire
Mar-21-19 07:56AM  Liquidia Technologies Announces Pricing of Offering of Common Stock GlobeNewswire -18.55%
Mar-19-19 08:57AM  Morrisville company looks to Wall Street again American City Business Journals -13.82%
Mar-18-19 04:45PM  Liquidia Technologies Announces Proposed Offering of Common Stock GlobeNewswire +5.56%
Mar-11-19 07:00AM  Liquidias LIQ861 Meets Primary Endpoint in Pivotal Phase 3 INSPIRE Study in Patients with Pulmonary Arterial Hypertension GlobeNewswire
Feb-26-19 07:00AM  Liquidia Technologies Reports Fourth Quarter and Full-Year 2018 Financial Results and Provides Corporate Update GlobeNewswire -5.46%
Feb-13-19 04:30PM  Liquidia Technologies to Report 2018 Financial Results and Provide Corporate Update on February 26, 2019 GlobeNewswire
Jan-07-19 07:00AM  Liquidia Technologies Reports Positive Interim LIQ861 Safety Data on 109 Patients from Pivotal INSPIRE Trial GlobeNewswire
Dec-27-18 09:23AM  Stocks down in December for pharma firms in the Triangle American City Business Journals -9.62%
Nov-27-18 04:45PM  Liquidia Technologies Provides Leadership Update GlobeNewswire
02:04PM  Liquidia Technologies Inc (NASDAQ:LQDA): Time For A Financial Health Check Simply Wall St.
Nov-14-18 04:30PM  Liquidia Technologies Recipient of Best-in-Class Public Offering Award at Southeast BIO GlobeNewswire +14.65%
08:00AM  Liquidia Technologies to Present LIQ865 Phase 1a Data at ASRAs 17th Annual Pain Medicine Meeting GlobeNewswire
07:55AM  Analysis: Positioning to Benefit within Harvest Capital Credit, Zynga, Unique Fabricating, SJW Group, Liquidia Technologies, and Rave Restaurant Group Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Nov-09-18 08:00AM  Liquidia Technologies to Present at Jefferies London Healthcare Conference GlobeNewswire
Nov-01-18 08:14AM  Liquidia Technologies refocuses efforts American City Business Journals
Oct-31-18 07:00AM  Liquidia Technologies Reports Third Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire -12.55%
Oct-23-18 08:00AM  Liquidia Technologies to Provide Third Quarter 2018 Corporate Update on October 31, 2018 GlobeNewswire -7.82%
Sep-24-18 08:00AM  Liquidia Technologies Added to Russell 2000®, 3000® and Microcap® Indexes GlobeNewswire
Aug-20-18 03:45PM  Liquidia Well-Positioned With PRINT, Jefferies Says Benzinga +9.73%
Aug-09-18 08:00AM  Liquidia Technologies to Present at Wedbush PacGrow Healthcare Conference GlobeNewswire +9.66%
Jul-31-18 02:45PM  Liquidia closes IPO American City Business Journals
Jul-30-18 04:15PM  Liquidia Technologies Announces Closing of Initial Public Offering Business Wire
Jul-25-18 07:02PM  Liquidia Technologies Announces Pricing of Initial Public Offering Business Wire
Jul-21-18 09:03AM  The IPO Outlook For The Week: Tech & International Exposure Benzinga
Liquidia Technologies, Inc., a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of human therapeutics. Its lead product candidate, LIQ861, an inhaled dry powder formulation of treprostinil that is in Phase III clinical trials used for the treatment of pulmonary arterial hypertension. The company is also developing LIQ865, which completed Phase 1 clinical trials for the treatment of local post-operative pain. It has collaboration agreements with GlaxoSmithKline plc and the University of North Carolina. Liquidia Technologies, Inc. was founded in 2004 and is headquartered in Morrisville, North Carolina.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Canaan VIII LP10% OwnerDec 27Buy3.13319,488999,9972,917,169Jan 10 04:20 PM
open in yahoo | open in reuters | open in google